Financials

Filing date	Form	Description	Filing Group	View
Sep 18, 2019	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0000899243-19-023827.pdf 0000899243-19-023827.rtf 0000899243-19-023827.xls
Sep 17, 2019	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Registration Statements	View HTML 0001193125-19-246866.pdf 0001193125-19-246866.rtf
Sep 13, 2019	EFFECT	EFFECT	Other	View HTML 9999999995-19-002090.pdf 9999999995-19-002090.rtf 9999999995-19-002090.xls
Sep 11, 2019	CORRESP	CORRESP	Other	View HTML 0001193125-19-242965.pdf 0001193125-19-242965.rtf 0001193125-19-242965.xls
Sep 04, 2019	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001157523-19-001946.pdf 0001157523-19-001946.rtf 0001157523-19-001946.xls
Aug 30, 2019	S-3/A	Pre-effective amendment to an S-3 filing	Registration Statements	View HTML 0001193125-19-235325.pdf 0001193125-19-235325.rtf 0001193125-19-235325.xls
Aug 30, 2019	CORRESP	CORRESP	Other	View HTML 0001193125-19-235328.pdf 0001193125-19-235328.rtf
Aug 20, 2019	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001157523-19-001887.pdf 0001157523-19-001887.rtf 0001157523-19-001887.xls
Aug 20, 2019	UPLOAD	UPLOAD	Other	View HTML 0000000000-19-012674.pdf 0000000000-19-012674.rtf
Aug 13, 2019	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001157523-19-001827.pdf 0001157523-19-001827.rtf 0001157523-19-001827.xls

Data provided by Kaleidoscope.

Synlogic Therapeutics